Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
October 30, 2017
Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase 1b Study of OXi4503 in Acute Myeloid Leukemia
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan ...
October 30, 2017
Transgene to Present Additional Immunology Data from the TIME trial with TG4010 in patients with advanced lung cancer at SITC 2017
STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (TNG.PA), a biotech company that designs and develops viral-based immunotherapies, will be presenting a poster on additional immunology data generated from ...
October 30, 2017
Achaogen to Host Conference Call and Webcast of Third Quarter 2017 Financial Results on November 8, 2017
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant ...
October 27, 2017
Onxeo Provides Strategy Update and Reports 2017 Third Quarter Financial Information
PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (ONXEO.PA) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO – ISIN FR0010095596), (“Onxeo” or the “Company”), a clinical-stage biotechnology company specializing ...
October 27, 2017
CorMedix Inc. to Present Candida auris Susceptibility Data at 2nd Annual Gulf Congress of Clinical Microbiology and Infectious Diseases
BERKELEY HEIGHTS, NJ / ACCESSWIRE / October 26, 2017 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
October 27, 2017
DURECT Corporation Invites You to Join its Third Quarter 2017 Earnings Conference Call
CUPERTINO, Calif., Oct. 26, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's (DRRX) third quarter 2017 financial results press release, you are invited to listen to a conference ...
October 27, 2017
ASPiRA Labs Lands Strategic Managed Care Coverage and Medicaid Licensure for OVA1®
AUSTIN, Texas, Oct. 27, 2017 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (VRML), today announced it has entered into agreements with Joint Venture Hospital Laboratories, LLC ("JVHL"), ...
October 27, 2017
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2017 and Recent Corporate Progress
SAN DIEGO--(BUSINESS WIRE) -- La Jolla Pharmaceutical Company (LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes ...
October 27, 2017
Biophytis Appoints Professor Thomas Voit to Scientific Advisory Board to Help Accelerate Pipeline Programs in Orphan Pediatric Diseases
BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company focused on innovative therapeutics to restore the muscular and visual functions in diseases with significant unmet medical needs, ...
October 27, 2017
MediWound Announces Exercise of Underwriters’ Option to Purchase Additional Shares
YAVNE, Israel, Oct. 27, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe ...
October 26, 2017
Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen diabetic foot ulcer Phase 2 clinical trial
LAVAL, QC , Oct.  26, 2017 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) (Prometic) today announced that it has received Swedish Medical Products Agency (MPA) ...
October 26, 2017
Intec Pharma Names Walt Linscott as Chief Administrative Officer
JERUSALEM, October 26, 2017 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) (NTEC.TA), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, ...
October 26, 2017
iCAD’s PowerLook Tomo Detection for Digital Breast Tomosynthesis Named 2017 Product of the Year by New Hampshire High Technology Council
NASHUA, N.H., Oct. 26, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification ...
October 26, 2017
Catalyst Biosciences Announces the Appointment of Industry Veteran Andrea Hunt to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
October 26, 2017
Pernix Therapeutics to Report Third Quarter 2017 Financial Results on Tuesday, November 7
MORRISTOWN, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today that the ...
October 26, 2017
Arcturus Therapeutics Announces Presentations at Conferences in November
SAN DIEGO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it plans to present at three ...
October 26, 2017
Achaogen Submits Plazomicin New Drug Application (NDA) to the U.S. FDA for Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
October 26, 2017
Heron Therapeutics Granted FDA Fast Track Designation for HTX-011 to Reduce Postoperative Pain and the Need for Opioid Analgesics for 72 Hours
SAN DIEGO--(BUSINESS WIRE) -- Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel best-in-class treatments to address some ...
October 26, 2017
AIT Therapeutics Strengthens Executive Team with Three Key Senior Hires as Company Prepares for Upcoming Clinical Milestones
NEW YORK, Oct. 26, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
October 26, 2017
UroGen Pharma Expands Leadership Team, Appoints Industry Veterans Jeffrey Bova as Vice President of Commercial and James Ottinger as Vice President of Regulatory Affairs
RA’ANANA, Israel, and NEW YORK, Oct. 26, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
Page 129 of 162